Target Price | CHF4,228.71 |
Price | CHF3,802.00 |
Potential | 11.22% |
Number of Estimates | 21 |
21 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,228.71. This is 11.22% higher than the current stock price. The highest price target is CHF5,100.00 34.14% , the lowest is CHF3,400.00 10.57% . | |
A rating was issued by 23 analysts: 8 Analysts recommend Givaudan to buy, 10 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 11.22% . Most analysts recommend the Givaudan stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 7.41 | 7.80 |
7.19% | 5.29% | |
EBITDA Margin | 23.87% | 24.16% |
12.12% | 1.23% | |
Net Margin | 14.72% | 14.85% |
13.88% | 0.91% |
20 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.8b . This is 5.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.0b 7.39% , the lowest is CHF7.7b 3.64% .
This results in the following potential growth metrics:
2024 | CHF7.4b | 7.19% |
---|---|---|
2025 | CHF7.8b | 5.29% |
2026 | CHF8.2b | 4.91% |
2027 | CHF8.6b | 5.13% |
2028 | CHF9.1b | 5.53% |
2029 | CHF9.7b | 6.92% |
20 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 6.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.9b 9.50% , the lowest is CHF1.7b 5.91% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF1.8b | 20.18% |
---|---|---|
2025 | CHF1.9b | 6.58% |
2026 | CHF2.0b | 5.03% |
2027 | CHF2.1b | 5.37% |
2028 | CHF2.1b | 2.92% |
2029 | CHF2.2b | 1.44% |
2024 | 23.87% | 12.12% |
---|---|---|
2025 | 24.16% | 1.23% |
2026 | 24.19% | 0.12% |
2027 | 24.24% | 0.21% |
2028 | 23.64% | 2.48% |
2029 | 22.43% | 5.12% |
14 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.2b . This is 6.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 9.74% , the lowest is CHF1.1b 1.82% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.1b | 22.06% |
---|---|---|
2025 | CHF1.2b | 6.29% |
2026 | CHF1.3b | 8.57% |
2027 | CHF1.4b | 7.58% |
2028 | CHF1.4b | 1.46% |
2029 | CHF1.4b | 1.35% |
2024 | 14.72% | 13.88% |
---|---|---|
2025 | 14.85% | 0.91% |
2026 | 15.37% | 3.50% |
2027 | 15.73% | 2.34% |
2028 | 15.13% | 3.81% |
2029 | 14.34% | 5.22% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 118.17 | 125.60 |
22.06% | 6.29% | |
P/E | 30.27 | |
EV/Sales | 5.01 |
14 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF125.60 . This is 6.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF129.68 9.74% , the lowest is CHF116.02 1.82% .
This results in the following potential growth metrics and future valuations:
2024 | CHF118.17 | 22.06% |
---|---|---|
2025 | CHF125.60 | 6.29% |
2026 | CHF136.37 | 8.57% |
2027 | CHF146.71 | 7.58% |
2028 | CHF148.85 | 1.46% |
2029 | CHF150.87 | 1.36% |
Current | 32.17 | 24.13% |
---|---|---|
2025 | 30.27 | 5.91% |
2026 | 27.88 | 7.90% |
2027 | 25.92 | 7.03% |
2028 | 25.54 | 1.47% |
2029 | 25.20 | 1.33% |
Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.01 and an P/S ratio of 4.49 .
This results in the following potential growth metrics and future valuations:
Current | 5.27 | 13.61% |
---|---|---|
2025 | 5.01 | 5.01% |
2026 | 4.77 | 4.68% |
2027 | 4.54 | 4.88% |
2028 | 4.30 | 5.24% |
2029 | 4.02 | 6.47% |
Current | 4.73 | 13.60% |
---|---|---|
2025 | 4.49 | 5.02% |
2026 | 4.28 | 4.68% |
2027 | 4.08 | 4.88% |
2028 | 3.86 | 5.24% |
2029 | 3.61 | 6.47% |
Analyst | Rating | Action | Date |
---|---|---|---|
RESEARCH PARTNERS AG |
Hold
➜
Buy
|
Upgrade | Jan 06 2025 |
BNP PARIBAS EXANE |
Neutral
➜
Neutral
|
Unchanged | Jan 05 2025 |
BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Dec 16 2024 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Dec 08 2024 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Nov 07 2024 |
DZ BANK |
Hold
➜
Hold
|
Unchanged | Oct 16 2024 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Oct 10 2024 |
Analyst Rating | Date |
---|---|
Upgrade
RESEARCH PARTNERS AG:
Hold
➜
Buy
|
Jan 06 2025 |
Unchanged
BNP PARIBAS EXANE:
Neutral
➜
Neutral
|
Jan 05 2025 |
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Dec 16 2024 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Dec 08 2024 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Nov 07 2024 |
Unchanged
DZ BANK:
Hold
➜
Hold
|
Oct 16 2024 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Oct 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.